Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the Aseptic Process Simulation (APS) qualification of its sterile manufacturing facility and newly available fill/finish capacity.

MariMed Q1 Revenue Falls 4% Sequentially

MariMed Reports First Quarter 2023 Earnings NORWOOD, Mass., May 08, 2023 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a

May 9, 2023

Dr. James Gill’s insights on combating the global crisis of antimicrobial resistance

Dr. James Gill, a Clinical Lecturer at the University of Warwick and a practicing GP, will attend a pivotal event hosted at the House of

April 27, 2024

Exclusive: Moldova clears first gene editing study for HBV in humans

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.